Jane was drinking three bottles of wine a night and struggling to dull the 'alcohol noise' in her head. Then she tried the ...

The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

There appears to be limited evidence supporting the use of epidural steroid injections for certain types of chronic lower ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Depression hits the whole body, speeding the onset of long-term physical ills as people age, new research contends.

It’s a pill, not an injection ... though it is some years from being ready for the market. Could Ozempic be overtaken? Novo Nordisk might do well to consider the fate of another Nordic firm ...

There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.

In 2025, we’re still talking about the tapeworm diet. Here’s why you should stay well away from the extreme weight-loss ...

Ozempic/Wegovy is the first drug on HHS's 2025 ... shorter window time for small molecule drugs vs biologics, dubbed the "pill penalty" by the industry. "In rushing out this list in their final ...

He also published one of the first case series that found semaglutide, the active ingredient in Ozempic, to effectively ... “It’s not just a pill that you’re going to give to a person.